Proclaim is now approved for patients with painful diabetic peripheral neuropathy, Abbott said in a Jan. 26 news release. The SCS system also connects to the Abbott’s NeuroSphere virtual clinic, which allows for remote communication with physicians.
Abbott’s Proclaim SCS was approved for chronic pain treatment in 2019.
